Skip to content
healthcare.dev

Dalbavancin

NDC 71839-144, dalbavancin, injection, powder, lyophilized, for solution, from BE Pharmaceuticals Inc..

Product NDC
71839-144
Status
Listed
Labeler
BE Pharmaceuticals Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA219604
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71839-144 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DALBAVANCIN HYDROCHLORIDE500 mg/25mL

Pharmacologic classes

Lipoglycopeptide Antibacterial [EPC]; Lipoglycopeptides [CS]

Package NDCNDC-11Package
71839-144-01718390144011 VIAL in 1 CARTON (71839-144-01) / 25 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6c188995-ab05-45c3-a3af-5b1bcd655fdc

Use it

Look up 71839-144 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71839-144 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71839-144. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.